Palisades Investment Partners’s Delcath Systems DCTH Stock Holding History

Palisades Investment Partners’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$293K	Buy	23,273 +9,510	+69%	+$105K	0.08%	53
2026 Q1	$128K	Sell	13,763 -253,375	-95%	-$2.45M	0.05%	51
2025 Q4	$2.7M	Buy	267,138 +4,196	+2%	+$41.7K	1.02%	34
2025 Q3	$2.83M	Sell	262,942 -7,368	-3%	-$82.3K	1.11%	34
2025 Q2	$3.68M	Buy	270,310 +99,226	+58%	+$1.38M	1.61%	23
2025 Q1	$2.18M	Buy	171,084 +1,757	+1%	+$24.9K	1.09%	33
2024 Q4	$2.04M	Buy	169,327 +19,671	+13%	+$208K	0.86%	35
2024 Q3	$1.35M	Buy	+149,656	New	+$1.3M	0.59%	37

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Palisades Investment Partners's DCTH Position: Q2 2026 in Review

Palisades Investment Partners increased its Delcath Systems (DCTH) stake by 69% in Q2 2026, buying an estimated $105K and bringing the position to 23,273 shares worth $293K. The position accounts for 0.08% of the portfolio, ranked #53.

Palisades Investment Partners first reported a position in DCTH in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.68M in Q2 2025. 120 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

Palisades Investment Partners held 23,273 shares of Delcath Systems worth $293K as of Q2 2026.
Palisades Investment Partners bought 9,510 Delcath Systems shares in Q2 2026, an estimated $105K.
Delcath Systems made up 0.08% of Palisades Investment Partners's portfolio in Q2 2026, its #53 holding.
Palisades Investment Partners first reported a position in Delcath Systems in Q3 2024 and has held it in 8 quarters since.
Palisades Investment Partners's Delcath Systems position peaked at $3.68M in Q2 2025.
120 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Palisades Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.